NCT06049134 2026-03-09
Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
M.D. Anderson Cancer Center
Phase 4 Active not recruiting
M.D. Anderson Cancer Center
Swedish Orphan Biovitrum
Pharmacyclics Switzerland GmbH
Kyowa Kirin Co., Ltd.
Pfizer
Ain Shams University